A new method to control the spread of cancer .. May occur a quantum leap in the way the control and treatment of cancer

U.S. scientists have developed a new bloody examination can occur quantum leap in the way doctors treat and control the spread of cancer.
The test is sensitive enough to detect any stray cancerous cell among about a billion blood cells, and can thus see whether the tumor has spread elsewhere in the body or the possibility of that.


It also shows test whether the level of blood cells carrying the cancer reduced response to treatment, which gives doctors measure the success of a clearer and analyzes the structure of biological cells to find out the following predictions of movement.


The Daily Telegraph that this test could replace the painful tissue sample currently used to monitor the growth of tumors, and can be used at the end of the day instead of other measures such as: Mammograms or binoculars for the detection of colon cancers are new.


And will start four major cancer hospitals in the United States testing procedure this year, will be used to detect the immediate examination of whether therapies for cancer patients present to prove their effectiveness.


It is noteworthy that biopsy needles that are diagnosed through which many cancers usually do not provide an adequate sample of how to inform doctors about the possibility of tumor growth.


To measure the size of the cancer patients undergoing a scan on for months after receiving the drug or radiotherapy. But the time lag means that they often die before finding an effective treatment plan.


Scientists hope that new blood can be examined by doctors measure the success of treatment more quickly, which means the possibility of experimenting with more options during the months of success or failure.


Said Dr. Daniel Haber, inventor of a test that doctors can provide treatment in a day and taking a sample from a patient's blood the next day to find out whether the cancer cells spread have disappeared.


It is expected that development will take examination, led by inventors from Boston and pharmaceutical company Johnson & Johnson, nearly five years, at a cost of about $ 30 million.
Daily Telegraph